Clinical Trials

Beech Tree Labs currently collaborates with Norwich Clinical Research Associates Ltd. for regulatory submissions and management of clinical trials. The Company is currently conducting FDA-authorized trials targeting recurrent oral herpes and urinary incontinence.

Beech Tree investigators have prior experience conducting 14 successful FDA-authorized clinical trials, 4 Institutional Review Board (IRB)-approved clinical trials, and 2 USDA clinical trials, all focusing on Resonant Molecular Signaling agents.  These include:

FDA Phase 2

• Acute myelogenous leukemia (AML) [2]
• Cancer-associated pain
• Myelodysplastic syndrome (MDS) [2]
• Prostate cancer, advanced
• Solid tumors
• Benign prostatic hyperplasia (BPH) [2, 1 failed]
• Chronic prostatitis
• Chronic bronchitis
• Chronic obstructive pulmonary disease (COPD)
• Cystic fibrosis
• Chronic fatigue syndrome
• Multiple sclerosis

Institutional Review Board (IRB)

• Cancer-associated pain
• Cardiomyopathy
• Osteoporosis
• Urinary incontinence

USDA

• Canine mast cell tumors
• Equine myositis